Further studies will be required to understand fully how SHORT syndrome–associated PIK3R1 mutations produce severe insulin resistance in humans, and to establish whether varying degrees of insulin resistance in different tissues are involved in the protection from dyslipidemia, fatty liver, and adiponectin suppression we report in this condition. Here, ADIPOQ is linked to metabolic syndrome.